- Home
- DGICA vs EYPT Comparison
DGICA vs EYPT Comparison
Compare DGICA & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DGICA
- EYPT
- Stock Information
- Founded
- DGICA 1986
- EYPT 1987
- Country
- DGICA United States
- EYPT United States
- Employees
- DGICA N/A
- EYPT N/A
- Industry
- DGICA Property-Casualty Insurers
- EYPT Biotechnology: Laboratory Analytical Instruments
- Sector
- DGICA Finance
- EYPT Industrials
- Exchange
- DGICA Nasdaq
- EYPT Nasdaq
- Market Cap
- DGICA 510.1M
- EYPT 489.4M
- IPO Year
- DGICA N/A
- EYPT 2005
- Fundamental
- Price
- DGICA $15.58
- EYPT $6.15
- Analyst Decision
- DGICA
- EYPT Strong Buy
- Analyst Count
- DGICA 0
- EYPT 8
- Target Price
- DGICA N/A
- EYPT $25.71
- AVG Volume (30 Days)
- DGICA 88.5K
- EYPT 869.2K
- Earning Date
- DGICA 02-20-2025
- EYPT 03-06-2025
- Dividend Yield
- DGICA 4.36%
- EYPT N/A
- EPS Growth
- DGICA 1022.92
- EYPT N/A
- EPS
- DGICA 1.50
- EYPT N/A
- Revenue
- DGICA $989,605,000.00
- EYPT $45,713,000.00
- Revenue This Year
- DGICA N/A
- EYPT N/A
- Revenue Next Year
- DGICA $5.78
- EYPT N/A
- P/E Ratio
- DGICA $10.53
- EYPT N/A
- Revenue Growth
- DGICA 6.71
- EYPT 7.50
- 52 Week Low
- DGICA $12.26
- EYPT $5.90
- 52 Week High
- DGICA $17.00
- EYPT $29.31
- Technical
- Relative Strength Index (RSI)
- DGICA 62.93
- EYPT 36.22
- Support Level
- DGICA $15.05
- EYPT $5.90
- Resistance Level
- DGICA $15.96
- EYPT $6.67
- Average True Range (ATR)
- DGICA 0.38
- EYPT 0.71
- MACD
- DGICA 0.08
- EYPT -0.04
- Stochastic Oscillator
- DGICA 77.78
- EYPT 8.99
About DGICA Donegal Group Inc.
Donegal Group Inc is an insurance holding company that offers businesses and individuals personal and commercial lines of property and casualty insurance. The company's reportable segments are its Investment function, Personal lines of insurance, and Commercial lines of insurance. Personal lines products consist mainly of homeowners and private passenger automobile policies. The Commercial lines products of its insurance subsidiaries consist mainly of commercial automobile, commercial multi-peril, and workers' compensation policies. The group mainly operates in the United States.
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.